Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3323241
Max Phase: Preclinical
Molecular Formula: C23H25NO7
Molecular Weight: 427.45
Molecule Type: Small molecule
Associated Items:
ID: ALA3323241
Max Phase: Preclinical
Molecular Formula: C23H25NO7
Molecular Weight: 427.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(c(C)c3c(c2OC)OCO3)CCN1C
Standard InChI: InChI=1S/C23H25NO7/c1-11-12-8-9-24(2)17(15(12)21(28-5)22-18(11)29-10-30-22)19-13-6-7-14(26-3)20(27-4)16(13)23(25)31-19/h6-7,17,19H,8-10H2,1-5H3/t17-,19+/m1/s1
Standard InChI Key: UVSRVHUEWXARJU-MJGOQNOKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 427.45 | Molecular Weight (Monoisotopic): 427.1631 | AlogP: 3.19 | #Rotatable Bonds: 4 |
Polar Surface Area: 75.69 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.07 | CX Basic pKa: 7.13 | CX LogP: 3.09 | CX LogD: 2.91 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.69 | Np Likeness Score: 1.30 |
1. Porcù E, Sipos A, Basso G, Hamel E, Bai R, Stempfer V, Udvardy A, Bényei AC, Schmidhammer H, Antus S, Viola G.. (2014) Novel 9'-substituted-noscapines: synthesis with Suzuki cross-coupling, structure elucidation and biological evaluation., 84 [PMID:25050880] [10.1016/j.ejmech.2014.07.050] |
Source(1):